StockGuru Shines its Spotlight on Genesis Biopharma, Inc. (OTCBB: GNBP) As It Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise — Septembert 20, 2011

StockGuru Shines its Spotlight on Genesis Biopharma, Inc. (OTCBB: GNBP) As It Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise — Septembert 20, 2011

by | Sep 20, 2011 | Latest Spotlights

(Dallas, TX. – September 20, 2011) StockGuru Shines its Spotlight on Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company developing targeted cancer immunotherapies, yesterday announced the engagement of four senior industry consultants.  The Company...